SWM
BEAT

SeaCrest Wealth Management’s BioTelemetry, Inc. BEAT Stock Holding History

SeaCrest Wealth Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10
Closed – – 2408
2018
Q2 		$0 Hold
10
– – ﹤0.01% 2374
2018
Q1 		$0 Sell
10
-100
-91% -$3.29K ﹤0.01% 2369
2017
Q4 		$3K Buy
+110
New +$3.19K ﹤0.01% 1970

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.28B AUM 23.15% 1-Year Est. Return

SeaCrest Wealth Management's BEAT Position: Q3 2018 in Review

SeaCrest Wealth Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2018, closing a stake of 10 shares.

SeaCrest Wealth Management first reported a position in BEAT in Q4 2017 and held it in 3 quarters. The position peaked at $3K in Q4 2017. 256 funds tracked by Wall St. Rank hold BEAT as of Q3 2018.

  • SeaCrest Wealth Management reported no remaining BioTelemetry, Inc. position as of Q3 2018 after selling out during the quarter.
  • SeaCrest Wealth Management sold 10 BioTelemetry, Inc. shares in Q3 2018.
  • SeaCrest Wealth Management first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 3 quarters.
  • SeaCrest Wealth Management's BioTelemetry, Inc. position peaked at $3K in Q4 2017.
  • 256 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2018.

Based on SeaCrest Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.